Novel antigens of CAR T cell therapy: New roads; old destination

Novel antigens of CAR T cell therapy: New roads; old destination

Chimeric antigen receptor T cell (CAR-T) therapy has so far proved itself as a reliable therapeutic option for the treatment of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), and mantle cell lymphoma (MCL). However...

Full description

Bibliographic Details
Main Authors: Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani, Fatemeh Rahbarizadeh
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Translational Oncology
Subjects:
Cancer immunotherapy
Adoptive cell therapy
CasMab
Tumor-associated antigens
Chimeric antigen receptor
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321000711

Internet

http://www.sciencedirect.com/science/article/pii/S1936523321000711

Similar Items